Rxmp Therapeutics, INC.
At a glance
EmployeesNot reported
In business since2013
HeadquartersMiami, FL
US patents1
SAM.gov UEIG4WJF178TNG5
CAGE code70M82
Incorporated inFL
- developing
- agents
- prevent excessive bleeding
- red cell-derived microparticles
- healthcare
- improving
- outcomes
- reducing costs
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
1 US patent granted FEB 8, 2022.
Pharmaceuticals 1
- Composition comprising red cell-derived microparticles and method of treating excessive bleedingUS 11,241,457 · granted FEB 8, 2022
Granted to RxMP Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Rxmp Therapeutics, INC. | Miami | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.